Fused heteroaromatic glucokinase activators

Details for Australian Patent Application No. 2002221902 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Mahaney, Paige Erin; Corbett, Wendy Lea; Grimbsy, Joseph Samuel; Kester, Robert Francis; Sarabu, Ramakanth; Haynes, Nancy-Ellen

Agent Spruson & Ferguson

Pub. Number AU-B-2002221902

PCT Pub. Number WO02/46173

Priority 60251637 06.12.00 US

Filing date 28 November 2001

Wipo publication date 18 June 2002

Acceptance publication date 23 November 2006

International Classifications

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

23 November 2006 Application Accepted

  Published as AU-B-2002221902

22 March 2007 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221903

2002221901